Fluorescent marks for use in medical devices (Q11207)

From EU Knowledge Graph
Revision as of 15:27, 22 October 2020 by DG Regio (talk | contribs) (‎Created claim: summary (P836): The project is focused on R & D technologies for the preparation of specific fluorescent brands, called tandem fluorochromes, which will enable the production of a group of products – In vitro diagnostic (IVD) medical devices for the identification of malignant, reactive and normal blood cells in clinical samples using flow cytometry. Compliance with the requirements of regulation 21 CFR 820 will guarantee the possibility of registration of new...)
Jump to navigation Jump to search
Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
Fluorescent marks for use in medical devices
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    4,208,983.49 Czech koruna
    0 references
    168,359.34 Euro
    10 January 2020
    0 references
    10,525,090.0 Czech koruna
    0 references
    421,003.60 Euro
    10 January 2020
    0 references
    39.99 percent
    0 references
    20 April 2017
    0 references
    18 April 2020
    0 references
    EXBIO Praha, a.s.
    0 references
    0 references

    49°59'0.49"N, 14°30'9.11"E
    0 references
    25250
    0 references
    Projekt je zaměřen na VaV technologie přípravy specifických fluorescenčních značek, tzv. tandemových fluorochromů, která umožní výrobu skupiny produktů - In vitro diagnostických (IVD) zdravotnických prostředků pro identifikaci maligních, reaktivních a normálních krevních buněk v klinických vzorcích pomocí průtokové cytometrie. Splněním požadavků regulace 21 CFR 820 bude zaručena možnost registrace nových produktů pro klinické aplikace na celosvětových trzích, včetně USA. a. (Czech)
    0 references
    The project is focused on R & D technologies for the preparation of specific fluorescent brands, called tandem fluorochromes, which will enable the production of a group of products – In vitro diagnostic (IVD) medical devices for the identification of malignant, reactive and normal blood cells in clinical samples using flow cytometry. Compliance with the requirements of regulation 21 CFR 820 will guarantee the possibility of registration of new products for clinical applications in global markets, including USA. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/16_083/0010233
    0 references